Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes. To support rigorous… Read more











![Chemical structure of (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F915095-94-2-3S-3-4-2-Chloro-5-iodophenylmethylphenoxytetrahydrofuran.png&w=3840&q=75)





































Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes. To support rigorous pharmaceutical analysis, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, critical process-related impurities, potential degradation products, and metabolites. These compounds are essential for laboratories conducting impurity profiling, method validation, and stability testing. Researchers utilize these high-quality standards—including stable isotope-labelled compounds—for precise identification and quantification in complex matrices using analytical techniques such as HPLC, LC-MS, and NMR. By providing these materials, the catalogue facilitates compliance with regulatory expectations for quality control and the toxicological evaluation of drug-related impurities during the lifecycle of the pharmaceutical product.